Free Trial
NASDAQ:NXGL

NEXGEL (NXGL) Stock Price, News & Analysis

NEXGEL logo
$2.85 -0.16 (-5.32%)
Closing price 04:00 PM Eastern
Extended Trading
$2.88 +0.02 (+0.88%)
As of 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About NEXGEL Stock (NASDAQ:NXGL)

Key Stats

Today's Range
$2.85
$3.01
50-Day Range
$2.66
$3.82
52-Week Range
$1.84
$5.10
Volume
12,390 shs
Average Volume
64,601 shs
Market Capitalization
$19.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Remove Ads

NEXGEL Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
14th Percentile Overall Score

NXGL MarketRank™: 

NEXGEL scored higher than 14% of companies evaluated by MarketBeat, and ranked 891st out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for NEXGEL.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NEXGEL is -4.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NEXGEL is -4.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    NEXGEL has a P/B Ratio of 3.17. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about NEXGEL's valuation and earnings.
  • Percentage of Shares Shorted

    2.00% of the float of NEXGEL has been sold short.
  • Short Interest Ratio / Days to Cover

    NEXGEL has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NEXGEL has recently increased by 5.12%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    NEXGEL does not currently pay a dividend.

  • Dividend Growth

    NEXGEL does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.00% of the float of NEXGEL has been sold short.
  • Short Interest Ratio / Days to Cover

    NEXGEL has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NEXGEL has recently increased by 5.12%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    NEXGEL has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for NEXGEL this week, compared to 1 article on an average week.
  • Search Interest

    Only 2 people have searched for NXGL on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, NEXGEL insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $55,730.00 in company stock.

  • Percentage Held by Insiders

    24.86% of the stock of NEXGEL is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 2.21% of the stock of NEXGEL is held by institutions.

  • Read more about NEXGEL's insider trading history.
Receive NXGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NEXGEL and its competitors with MarketBeat's FREE daily newsletter.

NXGL Stock News Headlines

Contrasting TELA Bio (NASDAQ:TELA) & NEXGEL (NASDAQ:NXGL)
DOGE tax surprise
Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax authorities have bought a powerful new AI supercomputer, worth millions of dollars. It's the most advanced technology offered by AI giant Nvidia. And it's almost certainly going to be used to advance Elon Musk's real agenda with DOGE... the massive, rapid roll out of AI across the entire federal government.
NEXGEL Reports Record Revenue Growth in 2024
See More Headlines

NXGL Stock Analysis - Frequently Asked Questions

NEXGEL's stock was trading at $4.46 at the start of the year. Since then, NXGL shares have decreased by 36.1% and is now trading at $2.85.
View the best growth stocks for 2025 here
.

NEXGEL, Inc. (NASDAQ:NXGL) announced its quarterly earnings results on Monday, March, 24th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.10) by $0.02. The firm had revenue of $3.04 million for the quarter, compared to analyst estimates of $2.99 million. NEXGEL had a negative trailing twelve-month return on equity of 71.19% and a negative net margin of 52.60%.

NEXGEL (NXGL) raised $14 million in an initial public offering on Wednesday, December 22nd 2021. The company issued 2,100,000 shares at a price of $6.83 per share. Maxim Group LLC served as the underwriter for the IPO.

Shares of NXGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NEXGEL investors own include Lexicon Pharmaceuticals (LXRX), Aditxt (ADTX), Helius Medical Technologies (HSDT), Onconova Therapeutics (ONTX), EchoStar (SATS), American Battery Technology (ABML) and Aumann (AAG).

Company Calendar

Last Earnings
3/24/2025
Today
4/02/2025
Next Earnings (Estimated)
4/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NXGL
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,160,000.00
Pretax Margin
-56.85%

Debt

Sales & Book Value

Annual Sales
$8.69 million
Price / Cash Flow
N/A
Book Value
$0.90 per share
Price / Book
3.29

Miscellaneous

Free Float
5,103,000
Market Cap
$20.14 million
Optionable
Not Optionable
Beta
0.62
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:NXGL) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners